CCL1



CCL1

K1KK1S2SS2M3MM3Q4QQ4V5VV5P6PP6F7FF7S8SS8R9RR9C10CC10C11CC11F12FF12S13SS13F14FF14A15AA15E16EE16Q17QQ17E18EE18I19II19P20PP20L21LL21R22RR22A23AA23I24II24L25LL25C26CC26Y27YY27R28RR28N29NN29T30TT30S31SS31S32SS32I33II33C34CC34S35SS35N36NN36E37EE37G38GG38L39LL39I40II40F41FF41K42KK42L43LL43K44KK44R45RR45G46GG46K47KK47... and 26 more residue(s)...... and 26 more residue(s)

SMILES None
InChIKey None
Sequence KSMQVPFSRCCFSFAEQEIPLRAILCYRNTSSICSNEGLIFKLKRGKEACALDTVGWVQRHRKMLRHCPSKRK

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections


No bioactivity data available.

CCL1

K1KK1S2SS2M3MM3Q4QQ4V5VV5P6PP6F7FF7S8SS8R9RR9C10CC10C11CC11F12FF12S13SS13F14FF14A15AA15E16EE16Q17QQ17E18EE18I19II19P20PP20L21LL21R22RR22A23AA23I24II24L25LL25C26CC26Y27YY27R28RR28N29NN29T30TT30S31SS31S32SS32I33II33C34CC34S35SS35N36NN36E37EE37G38GG38L39LL39I40II40F41FF41K42KK42L43LL43K44KK44R45RR45G46GG46K47KK47... and 26 more residue(s)...... and 26 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections


Compound is not listed as a drug.